Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals - Guidance document
This is a public health concern resulting in significant costs to the health care system as well as individual impacts on Canadians. Health Canada's monitoring of therapeutic product safety plays a vital role in public health and patient safety, providing health care providers and patients with the most up-to-date knowledge for decision making. It also provides Health Canada with information needed to monitor the benefit-risk ratio of products and act to protect Canadians where appropriate.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-10-21
Data overview
- Formats
- HTML
- File languages
- English, French